ArticleJournal of biomedical materials research. Part B, Applied biomaterials2025
Aligned Collagen Sponges Loaded With Myogenic Factors to Enhance Skeletal Muscle Tissue Regeneration.
Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Mechanical and structural responses of silk fibroin scaffolds to MechanoCulture T6® bioreactor loading and enzymatic degradation.Journal of the mechanical behavior of biomedical materials · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Volumetric muscle loss (VML) is an injury which leads to debilitating loss of functionality of a muscle. Autologous tissue grafts are used as a standard treatment; however, these grafts often result in complications. Current scaffolds are limited in their ability to restore functionality of the injured muscle, which may be due to lack of cell recruitment to the scaffold and/or lack of sufficient myofiber formation. Our approach involves the controlled release of insulin-like growth factor-1 (IGF-1) from a biopolymer scaffold, as IGF-1 enhances both the proliferation and differentiation of myoblasts, which we hypothesize will enhance regeneration after VML. In this study, to facilitate a more controlled release of IGF-1, we added IGF-binding protein 5 (IGFBP-5) to anisotropic collagen sponges with finely tuned pore sizes via heparin conjugation to stabilize the IGFBP-5/IGF-1 complex. Scaffolds containing heparin, IGFBP-5, and IGF-1 induced the highest level of myofiber formation for up to 4 weeks, suggesting this scaffold system supported the sustained release of active IGF-1. Future studies will be used to implant these scaffolds into mouse models of VML and determine their effects on regeneration in vivo as well as on restoration of force production of the muscle.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.